Sildenafil Tablet, Film Coated
Product Images NDC 72865-103

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72865-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

A vertical bar chart showing percentage of patients reporting improvement by treatment group. The groups are placebo, sildenafil citrate tablets 25 mg, 50 mg, and 100 mg. The percentage improves progressively from placebo at 24% to 82% at the highest dose (100 mg). Sample sizes per group are displayed below each category.*

FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

A line graph comparing systolic blood pressure changes (mmHg) over 24 hours post-dose between Sildenafil 100 mg and placebo. The x-axis shows time from pre-dose to 24 hours, and the y-axis shows blood pressure change. Two lines represent mean changes for Sildenafil and placebo groups over time.*

FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

A line graph comparing the change in measurement (likely blood pressure) over time (hours) for two groups: one receiving placebo and the other treated with Sildenafil 25 mg. The x-axis shows time in hours postdose, and the y-axis represents the change from baseline in mmHg.*

FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

A line chart showing the percentage change in a variable over time (hours) for two treatments. The x-axis represents time postdose (hours) from 0 to 8. The y-axis shows percent change from baseline, ranging from -50% to 40%. Two lines are plotted: one in blue with circular markers representing Doxazosin + Placebo, and one in black with square markers representing Doxazosin + Sildenafil 50 mg. The chart compares the effects of these treatments over an 8-hour period.*

FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

A line graph showing the effect of two treatments, Doxazosin + Sildenafil 100 mg and Doxazosin + Placebo, on mean arterial pressure over time after dosing (hours). The x-axis represents time after dosing from 0 to 8 hours, and the y-axis shows the change in mean arterial pressure (mmHg), with values decreasing below zero initially and gradually approaching baseline.*

FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

A line graph depicting plasma concentration of a drug (ng/mL) over time post dose (hours) up to 24 hours. The chart compares treatment plasma levels for a commercial tablet of Sildenafil, showing an initial rise, peak, and gradual decline in concentration through the measured period.*

FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

A bar chart depicting the percentage of patients at endpoint across baseline scores from 0 to 5. Multiple bars for each score illustrate different groupings or categories, ranging from 0 to 5, with the legend showing distinct shading for each category. The y-axis represents the percentage of patients, and the x-axis shows baseline scores.*

FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

A bar chart showing the percentage of patients at the endpoint distributed by baseline score values from 0 to 5. The legend indicates multiple categories labeled 00, 1, 2, 3, 4, and 5, corresponding to different bar patterns or colors representing patient groups or categories across baseline scores.*

FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Chemical structure of Sildenafil, showing its molecular components including a pyrazolopyrimidinone core and sulfonamide group, as depicted in the labeled diagram.*

FDA Label Image

Xlcare100mg.jpg (Xlcare100mg)

Sildenafil Tablets, USP 100 mg film-coated tablet label from XLCARE Pharmaceuticals Inc. The label displays the product name, strength, and dosage form, as well as packaging information for 30 tablets. It includes storage instructions, manufacturer contact details, and barcoding, with a designated unlabeled area marked "25 x 30 mm Un Varnish Area."*

FDA Label Image

Xlcare25mg (Xlcare25mg)

Label for Sildenafil Tablets, USP 25 mg film coated tablets by XLCARE Pharmaceuticals Inc. The label indicates oral route, prescription use, and packaging of 30 tablets. It includes storage instructions, manufacturer contact, and manufacturing details in the USA. A barcode and a 25 x 30 mm unvarnished area are also visible.*

FDA Label Image

Xlcare50mg (Xlcare50mg)

Label for Sildenafil Tablets, USP 50 mg, film-coated oral tablets by XLCARE Pharmaceuticals Inc. The container holds 30 tablets. The label includes storage instructions, manufacturer and contact information, and a barcode on the side. It specifies the equivalent sildenafil citrate content and dosing advice references the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.